Together, we reach far beyond the skin
Putting innovation into practice
with an extensive global portfolio of treatments in medical dermatology
Lifting the burden of disease
for nearly 100 million people who rely on our medicines every year
Shaping the future of what’s next
in partnership with healthcare organizations, scientists and patient groups
PRESS RELEASE
LEO Pharma delivers 7% revenue growth at CER in H1 2025 and achieves key milestones enabling future growth
In H1 2025, LEO Pharma delivered robust growth and significantly improved profitability, enabling an increase to the financial outlook for ...
Ballerup, Denmark, 18 August, 2025
Learn moreMORE NEWS
- Nov 17 2025 LEO Pharma Announces Positive Topline 32-Week Key Results in ADHAND Trial
- Nov 06 2025 LEO Pharma delivers 8% revenue growth at CER in 9M 2025 and updates full-year outlook
- Nov 03 2025 LEO Pharma strengthens leadership in medical dermatology with the appointment of Sophie Lamle as Chief Development Officer
ANNUAL REPORT 2024
LEO Pharma delivers double-digit revenue growth
LEO Pharma delivered another year of strong progress in 2024, with both sales growth and adjusted EBITDA margin ahead of the initial outlook for the year, putting the company on track to meet its profitability targets and to achieve its long-term strategic objectives.
Read more
CAREER
Discover how we innovate collectively.
For us, collaborating innovatively means continuously enhancing and expanding what's achievable for one another, our company, and our patients.